Tirzepatide

“Currently, Lily has a 105 studies going with trisapatide in these other diseases.”

“We currently have over a hundred clinical studies with the medicine going on for all kinds of other uses as well, not just slowing you down.”

“And then terzepatide, which you asked how much money we're making, but in, actually in Q-two, we reported global sales, which surpassed Keytruda to becoming the best-selling drug in the world, actually the best-selling drug in the world of all time.”

“On November of 2025, Lilly cut a deal with the Trump administration. I saw this to drop the price on terzepatide pretty significantly. I think it's like 50 bucks on Medicare.”